Science & Enterprise subscription

Follow us on Twitter

  • Results from a large-scale clinical trial show almost the same health outcomes for patients prescribed high or low…
    about 19 hours ago
  • New post on Science and Enterprise: Trial Shows Same High/Low Dose Aspirin Outcomes #Science #Business
    about 19 hours ago
  • Venture funding for start-ups providing artificial intelligence services in health care climbed to a record high vo…
    about 3 days ago
  • New post on Science and Enterprise: Infographic – Health Care A.I. Funds Jump in Q1 #Science #Business
    about 3 days ago
  • This New York Times essay got here just in time ... Your Car, Toaster, Even Washing Machine, Can’t Work Without The…
    about 3 days ago

Please share Science & Enterprise

IT Firm, University Partner on Alzheimer’s Research Platform

Illustration of brain (NIDA)

(National Institute of Drug Abuse)

16 April 2014. Parabon Computation in Reston, Virginia is creating a crowd-sourced computer network to provide the analytical power for two research studies on Alzheimer’s disease conducted in-house and with George Mason University in nearby Fairfax. The initiative, called Compute Against Alzheimer’s Disease, aims to tap into unused capacity of idle computers donated for this effort.

Compute Against Alzheimer’s Disease will support two research projects developing genetic diagnostics and simulations of chemical activity in the brain associated with the disorder. Ellen McRae, Parabon’s bioinformatics manager, is leading one study to identify genetic biomarkers that predict an individual’s risk of developing Alzheimer’s disease. McRae and colleagues will conduct in-depth analysis of data from the Alzheimer’s Disease Neuroimaging Initiative, an effort that detects and tracks Alzheimer’s disease in its earliest stages and tracks with biomarkers its progression over time.

The Parabon study aims to make stronger connections between genetic factors and risks of contracting Alzheimer’s disease. The findings are expected to offer earlier identification of people at all ages at risk of the disorder, which can encourage regular screenings and plan for changes in lifestyle and other environmental factors associated with Alzheimer’s disease.

The second research project is headed by Dmitri Klimov, a systems biologist at George Mason University. Klimov’s team is creating computer simulations of the effects of various peptides associated with the onset of Alzheimer’s disease on neurons, or brain cells. This research is looking into the damage that occurs when these peptides interact with the surface membranes of neurons, an undertaking that requires immense amounts of computing power. Understanding these interactions can help develop more effective therapies.

In December 2013, Parabon and Klimov were awarded a Small Business Technology Transfer grant from National Institute on Aging to develop new processes for simulations of molecular dynamics associated with Alzheimer’s disease, and write algorithms representing these dynamics to be offered as an online software service. The company earlier in 2013  received another small business research grant to develop software services supporting genetics research, this one with Dartmouth University.

To participate in Compute Against Alzheimer’s Disease, volunteers download a small application that activates when the computer is idle. Parabon then aggregates this volunteered capacity for the two research projects. The application also lets volunteers monitor the progress of the research projects for which their idle capacity is being used. The software runs on Windows, Mac OS, and Linux systems.

Read more:

*     *     *

Comments are closed.